Cargando…
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications
Systemic sclerosis (SSc; scleroderma) is characterized by life-threatening progressive multiorgan fibrosis orchestrated by profibrotic myofibroblasts originating from different sources. Because recent data demonstrated that the majority of myofibroblasts in a murine scleroderma model arise from adip...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723717/ https://www.ncbi.nlm.nih.gov/pubmed/31430950 http://dx.doi.org/10.3390/jcm8081256 |
_version_ | 1783448835109945344 |
---|---|
author | Manetti, Mirko Romano, Eloisa Rosa, Irene Fioretto, Bianca Saveria Praino, Emanuela Guiducci, Serena Iannone, Florenzo Ibba-Manneschi, Lidia Matucci-Cerinic, Marco |
author_facet | Manetti, Mirko Romano, Eloisa Rosa, Irene Fioretto, Bianca Saveria Praino, Emanuela Guiducci, Serena Iannone, Florenzo Ibba-Manneschi, Lidia Matucci-Cerinic, Marco |
author_sort | Manetti, Mirko |
collection | PubMed |
description | Systemic sclerosis (SSc; scleroderma) is characterized by life-threatening progressive multiorgan fibrosis orchestrated by profibrotic myofibroblasts originating from different sources. Because recent data demonstrated that the majority of myofibroblasts in a murine scleroderma model arise from adipocytic progenitors through the adipocyte-myofibroblast transition process, we sought to determine whether the SSc microenvironment may affect the differentiation potential of adipose-derived stem cells (ADSC). Normal human ADSC from three donors were treated with serum from SSc patients (n = 6), serum from healthy individuals (n = 6), or recombinant human transforming growth factor-β1 (TGFβ1) as positive control of myofibroblastic phenotype induction. ADSC were subjected to in vitro adipogenic differentiation for up to 21 days in the presence of different stimuli followed by lipid content quantification. In selected experiments, adipocytic and mesenchymal/myofibroblast marker gene and protein expression levels were assessed by Real-Time PCR, immunoblotting and immunofluorescence after administration of different stimuli for 72 and 96 h, respectively. Cell contractile phenotype was assayed by collagen gel contraction assay. Likewise stimulation with TGFβ1, SSc serum was able to significantly inhibit the adipocyte differentiation of ADSC as testified by a strong decrease in red-colored lipid droplets after 21 days of adipogenic induction. Treatment of ADSC either with SSc serum or TGFβ1 resulted in the acquisition of a myofibroblast-like phenotype characterized by a reduced expression of the adipocytic markers perilipin and adiponectin, a significant upregulation of the mesenchymal/myofibroblast markers α-SMA+ stress fibers, S100A4 and type I collagen, and an ability to effectively contract collagen gels. In SSc, the pathologic environment may favor the differentiation of ADSC into profibrotic and contractile myofibroblast-like cells. These findings strengthen the notion that the generation of myofibroblasts from ADSC may be relevant in SSc pathophysiology potentially representing a new target for the prevention/treatment of multiorgan fibrosis. |
format | Online Article Text |
id | pubmed-6723717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67237172019-09-10 Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications Manetti, Mirko Romano, Eloisa Rosa, Irene Fioretto, Bianca Saveria Praino, Emanuela Guiducci, Serena Iannone, Florenzo Ibba-Manneschi, Lidia Matucci-Cerinic, Marco J Clin Med Article Systemic sclerosis (SSc; scleroderma) is characterized by life-threatening progressive multiorgan fibrosis orchestrated by profibrotic myofibroblasts originating from different sources. Because recent data demonstrated that the majority of myofibroblasts in a murine scleroderma model arise from adipocytic progenitors through the adipocyte-myofibroblast transition process, we sought to determine whether the SSc microenvironment may affect the differentiation potential of adipose-derived stem cells (ADSC). Normal human ADSC from three donors were treated with serum from SSc patients (n = 6), serum from healthy individuals (n = 6), or recombinant human transforming growth factor-β1 (TGFβ1) as positive control of myofibroblastic phenotype induction. ADSC were subjected to in vitro adipogenic differentiation for up to 21 days in the presence of different stimuli followed by lipid content quantification. In selected experiments, adipocytic and mesenchymal/myofibroblast marker gene and protein expression levels were assessed by Real-Time PCR, immunoblotting and immunofluorescence after administration of different stimuli for 72 and 96 h, respectively. Cell contractile phenotype was assayed by collagen gel contraction assay. Likewise stimulation with TGFβ1, SSc serum was able to significantly inhibit the adipocyte differentiation of ADSC as testified by a strong decrease in red-colored lipid droplets after 21 days of adipogenic induction. Treatment of ADSC either with SSc serum or TGFβ1 resulted in the acquisition of a myofibroblast-like phenotype characterized by a reduced expression of the adipocytic markers perilipin and adiponectin, a significant upregulation of the mesenchymal/myofibroblast markers α-SMA+ stress fibers, S100A4 and type I collagen, and an ability to effectively contract collagen gels. In SSc, the pathologic environment may favor the differentiation of ADSC into profibrotic and contractile myofibroblast-like cells. These findings strengthen the notion that the generation of myofibroblasts from ADSC may be relevant in SSc pathophysiology potentially representing a new target for the prevention/treatment of multiorgan fibrosis. MDPI 2019-08-19 /pmc/articles/PMC6723717/ /pubmed/31430950 http://dx.doi.org/10.3390/jcm8081256 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Manetti, Mirko Romano, Eloisa Rosa, Irene Fioretto, Bianca Saveria Praino, Emanuela Guiducci, Serena Iannone, Florenzo Ibba-Manneschi, Lidia Matucci-Cerinic, Marco Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications |
title | Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications |
title_full | Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications |
title_fullStr | Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications |
title_full_unstemmed | Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications |
title_short | Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications |
title_sort | systemic sclerosis serum steers the differentiation of adipose-derived stem cells toward profibrotic myofibroblasts: pathophysiologic implications |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723717/ https://www.ncbi.nlm.nih.gov/pubmed/31430950 http://dx.doi.org/10.3390/jcm8081256 |
work_keys_str_mv | AT manettimirko systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications AT romanoeloisa systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications AT rosairene systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications AT fiorettobiancasaveria systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications AT prainoemanuela systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications AT guiducciserena systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications AT iannoneflorenzo systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications AT ibbamanneschilidia systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications AT matuccicerinicmarco systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications |